HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eliot Y Zhu Selected Research

Vemurafenib

10/2019Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma.
6/2019A simplified transposon mutagenesis method to perform phenotypic forward genetic screens in cultured cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eliot Y Zhu Research Topics

Disease

4Melanoma (Melanoma, Malignant)
10/2023 - 06/2019
1Neoplasms (Cancer)
05/2022

Drug/Important Bio-Agent (IBA)

2VemurafenibIBA
10/2019 - 06/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2023
1(4- (bis(4- chlorophenyl)methyl)- 1- piperazinyl)(5- methyl- 4- nitro- 1,2- oxazol- 3- yl)methanoneIBA
05/2022